Is SCHD Overrated? The Honest Math vs VIG & SPY

The Schwab U.S. Dividend Equity ETF (SCHD) boasts a $95.2 billion asset base and a low expense ratio of 0.06%. While it maintains a solid reputation, a comparative analysis with VIG and SPY reveals its unique focus on quality dividend-paying companies, excluding major growth stocks like Apple and Microsoft. Investors should note its current annualized yield of 3.12%, making it a compelling option for those seeking steady income in a diversified portfolio.

SCHD Has a Reputation. Let's Test It.

The Schwab U.S. Dividend Equity ETF (SCHD) is one of the most talked-about dividend funds in the market, with roughly $95.2 billion in assets and a rock-bottom 0.06% expense ratio. That popularity invites a fair question: is SCHD actually overrated, or does it earn its reputation?

The real question is not which fund is best. It is what each one is designed to do, and what tradeoffs come with that design. So we ran the honest math against two natural comparisons — VIG, the quality dividend-growth fund, and SPY, the market itself — on total return, dividend growth, yield, and concentration.

Some of it confirms the reputation. One widely repeated assumption doesn't survive contact with the numbers.

Performance and yield figures are historical and may change. Total return includes price movement and distributions where available. Past performance does not guarantee future results. Yield is not the same as total return.

What SCHD Actually Does

SCHD tracks the Dow Jones U.S. Dividend 100 Index. The methodology screens for companies with at least 10 consecutive years of dividends, then ranks them on quality factors — cash flow to debt, return on equity, dividend yield, and dividend growth — and holds the ~100 that score highest. It is a Large Value fund by category, carries a 3/5 Morningstar rating, and trades at $32.39 as of today, near the top of its 52-week range of $25.28–$32.66.

The screen produces a portfolio that looks very different from the S&P 500. Here's where the money sits.

SCHD — Sector Allocation
SCHD — Sector Allocation

SCHD's largest sector weights are Technology at 19.1%, Healthcare at 18.8%, Consumer Defensive at 18.1%, and Energy at 15.2%. The top holdings are Texas Instruments (5.7%), Qualcomm (5.4%), UnitedHealth (5.4%), Coca-Cola (4.1%), and Merck (3.9%).

Note what's missing: no Apple, Microsoft, Nvidia, or Amazon in the top ranks. The value-and-yield screen structurally excludes most of the mega-cap growth names that dominate the broad market. That single fact drives most of what follows.

The Income, in Real Numbers

Here is the figure most readers came for. SCHD's latest declared distribution was $0.2530 per share, declared 2026-06-24, and it pays quarterly. At four times that payout against today's price, the annualized run-rate is 3.12%.

Over the trailing twelve months, SCHD distributed $1.0480 per share, for a TTM distribution yield of 3.24% — in line with the 3.25% yield on the verified data feed. Distributions are variable going forward; SCHD's payout moves with the income its holdings generate, so treat these as the latest actuals, not a fixed coupon.

Income MetricSCHD
Latest declared distribution$0.2530 (2026-06-24)
FrequencyQuarterly
Annualized run-rate3.12%
TTM distributions$1.0480/share
TTM distribution yield3.24%

The Assumption That Doesn't Survive: Yield vs. Growth

Premium

Subscribe to Informed Investing

Subscribe free to read the full article — and unlock the complete archive.

We respect your inbox. Unsubscribe anytime.

We respect your inbox. Unsubscribe anytime.


Disclosure: This article is for informational and educational purposes only and is not financial, investment, tax, or legal advice. References to specific securities, tickers, companies, or strategies are provided for informational purposes only and do not constitute a recommendation, solicitation, or offer to buy or sell any security or financial product. We do not provide individualized advice or act as a fiduciary. Investing involves risk, including loss of principal, and past performance is not indicative of future results. We may hold positions in securities mentioned. You should independently verify information before acting on it and consult a qualified professional as needed.